{"organizations": [], "uuid": "098768462cd73f46e98911fe42cab3c1adc31a7f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-health-canada-approves-roches-ocre/brief-health-canada-approves-roches-ocrevus-for-type-of-multiple-sclerosis-idUSFWN1Q510T", "country": "US", "domain_rank": 408, "title": "BRIEF-Health Canada Approves Roche's Ocrevus For Type of Multiple Sclerosis", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-15T15:17:00.000+02:00", "replies_count": 0, "uuid": "098768462cd73f46e98911fe42cab3c1adc31a7f"}, "author": "", "url": "https://www.reuters.com/article/brief-health-canada-approves-roches-ocre/brief-health-canada-approves-roches-ocrevus-for-type-of-multiple-sclerosis-idUSFWN1Q510T", "ord_in_thread": 0, "title": "BRIEF-Health Canada Approves Roche's Ocrevus For Type of Multiple Sclerosis", "locations": [], "entities": {"persons": [], "locations": [{"name": "canada", "sentiment": "none"}], "organizations": [{"name": "brief-health canada approves roche", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 15, 2018 / 1:18 PM / Updated 6 minutes ago BRIEF-Health Canada Approves Roche's Ocrevus For Type of Multiple Sclerosis Reuters Staff Feb 15 (Reuters) - Roche Holding Ag: * HEALTH CANADA APPROVES OCREVUS® (OCRELIZUMAB) FOR CANADIANS LIVING WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS) * ‍ROCHE CANADA- HEALTH CANADA HAS APPROVED OCREVUS UNDER PROVISIONS MADE WITHIN ITS NOTICE OF COMPLIANCE WITH CONDITIONS POLICY​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-15T15:17:00.000+02:00", "crawled": "2018-02-15T15:43:03.003+02:00", "highlightTitle": ""}